Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors

Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors

Show other versions (1)

Bibliographic Details
Main Author:	Doran Ksienski
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-11-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://la-press.com/imatinib-mesylate-past-successes-and-future-challenges-in-the-treatmen-a2911

Similar Items

Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
by: Doran Ksienski
Published: (2011-01-01)

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
by: Omar S Din, et al.
Published: (2008-03-01)

ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor.
by: Lori Rink, et al.
Published: (2013-01-01)

MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate.
by: Warakaulle, DR, et al.
Published: (2006)

Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event
by: Yan ZhongShu, et al.
Published: (2011-11-01)

Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report
by: Waring Paul, et al.
Published: (2004-10-01)

Imatinib Mesylate Therapy in Advanced Gastrointestinal Stromal Tumors: Experience from a Single Institute
by: Hui-Hua Hsiao, et al.
Published: (2006-12-01)

Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate
by: Jan Yi-Yin, et al.
Published: (2006-10-01)

The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction
by: Schwarzbach Matthias HM, et al.
Published: (2008-04-01)

Tuberculous and Non-Tuberculous Granulomatous Lymphadenitis in Patients Receiving ImatinibMesylate (Glivec) for Metastatic Gastrointestinal Stromal Tumor
by: Abbas Agaimy, et al.
Published: (2013-03-01)

Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate
by: Čolović Radoje, et al.
Published: (2013-01-01)

A rare case of eye complications of gastric stromal tumor treatment using imatinib mesylate
by: E. B. Myakoshina, et al.
Published: (2020-09-01)

Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia
by: Yan Chen, et al.
Published: (2020-11-01)

Imatinibe mesilato no Brasil Imatinibe mesylate in Brazil
by: Marcos Lima
Published: (2005-09-01)

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
by: Richard Quek, et al.
Published: (2010-02-01)

Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
by: Demet Çekdemir, et al.
Published: (2020-03-01)

Recent Advancements in the Treatment of Rectal Gastrointestinal Stromal Tumor: In Era of Imatinib
by: Qu H, et al.
Published: (2022-03-01)

Pathological complete response in advanced gastric stromal tumor after imatinib mesylate therapy: a case report
by: Maazaz Khalid, et al.
Published: (2011-05-01)

Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
by: Wen-Kuan Huang, et al.
Published: (2020-05-01)

Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors
by: Lei Cao, et al.
Published: (2022-05-01)

Imatinib-induced podocytopathies in a patient with gastrointestinal stromal tumor
by: Gang Wang, et al.
Published: (2021-01-01)

Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour
by: Alexandre Bertucci, et al.
Published: (2019-08-01)

Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate <it>in vitro</it>
by: Lee Ho-Young, et al.
Published: (2009-11-01)

OUR EXPERIENCE WITH TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Mojca Modic, et al.
Published: (2004-12-01)

OUR EXPERIENCE IN TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Marjana Glaser, et al.
Published: (2004-04-01)

Effect of astaxanthin in imatinib mesylate-induced cardiotoxicity
by: İshak Suat Övey, et al.
Published: (2020-03-01)

The teratogenic effects of imatinib mesylate on rat fetuses
by: M.M. El Gendy, et al.
Published: (2015-01-01)

Mutations Associated with Imatinib Mesylate Resistance - Review
by: Linev Alexandar J., et al.
Published: (2018-12-01)

Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
by: Tielen Ronald, et al.
Published: (2012-06-01)

Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors
by: Xiangchen Hu, et al.
Published: (2022-09-01)

Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
by: Gibbons Joseph, et al.
Published: (2009-03-01)

Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
by: S. V. Boichuk, et al.
Published: (2015-06-01)

Secondary resistance to imatinib in gastrointestinal stromal tumors mediated by EPHB2
by: LIU Zong-hang, et al.
Published: (2022-12-01)

Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience
by: Bee, P.C., et al.
Published: (2006)

Complete response to imatinib treatment in jejunal leiomyosarcoma subsequently developing gastrointestinal stromal tumor and desmoid tumor
by: Yuji Kurihara, et al.
Published: (2014-01-01)

Molecular basis of primary and secondary resistance to imatinib mesylate
by: Abdul Aziz, Baba
Published: (2012)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate
by: Bożena Karolewicz, et al.
Published: (2019-07-01)

Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
by: Ryo Katsumata, et al.
Published: (2023-02-01)